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Abstract 
 
The cellular diversity of the hematopoietic system has been extensively 
studied and a plethora of cell-surface markers have been used to discriminate and 
prospectively purify different blood cell types. However, even within 
phenotypically-identical fractions of hematopoietic stem and progenitor cells 
(HSPCs) or lineage-restricted progenitors, significant functional heterogeneity is 
observed when single cells are analyzed. To address these challenges, 
researchers are now utilizing techniques to follow single cells and their progeny in 
order to improve our understanding for the underlying functional heterogeneity. On 
November 19th 2015 Drs. David Kent and Leïla Perié, two emerging young group 
leaders, presented their recent efforts to dissect the functional properties of 
individual cells in a webinar series organized by the International Society for 
Experimental Hematology (ISEH). Here, we provide a summary of the presented 
methods for cell labeling and clonal tracking and discuss how these different 
techniques have been employed to study hematopoiesis.  
 
 
Introduction 
 
Cellular heterogeneity within defined populations is becoming increasingly 
evident, and examination of cellular cohorts at the population level may thus 
obscure unique properties of individual cells. For example, hematopoietic stem and 
progenitor cells (HSPCs) are defined as the multipotent cells able to give rise to all 
hematopoietic (myeloid, lymphoid and thrombo-erythroid) lineages. However, 
there is growing evidence that subpopulations with inherent lineage bias exist. In 
addition, it has been postulated that committed progenitor populations may also 
be inherently heterogeneous. Given the heterogeneity of those cellular 
compartments, single-cell analysis is essential to define their functional potential. 
Single-cell sorting has been employed by the stem-cell field to address 
function of individual cells through either in vivo transplantation or in vitro culture 
experiments. With advances in sequencing technology, single cells can be 
assayed for their entire DNA sequence (genome) [1], RNA expression 
(transcriptome) [2], DNA methylation, chromatin structure (epigenomes) [3], and 
most recently the combination of both epigenome and transcriptome [4,5].  
Evaluation of genome-wide information at the single-cell level provides unique 
insights into the potential of individual cells, but requires the destruction of the 
starting cell, and thus functional output cannot be performed in tandem [6–8]. 
However, several tools have been developed to address this problem.  First, flow 
cytometric index-sorting allows for retrospective analysis by collecting and 
comparing parameters (light scattering properties, cell-surface marker expression 
levels) from each of the individual sorted cells from the same experiment. Second, 
viral barcoding provides a powerful way to assay multiple single cells in the same 
assay, but is limited by the genetic manipulation of starting cells. In tandem, such 
powerful methods can provide novel insights into the cellular heterogeneity of 
defined hematopoietic cell types. On November 19th 2015 Drs. David Kent and 
Leïla Perié highlighted techniques employed by their groups to study the functional 
properties of individual cells in a webinar series organized by the International 
Society for Experimental Hematology (ISEH) [9,10] and moderated by Dr. Claudia 
Waskow. Here, we present an overview of this webinar together with advantages 
and limitations of the main techniques used to identify functional differences 
between hematopoietic populations; index sorting and viral barcoding (Figure 1). 
 
Linking genome-wide expression data with functional properties in 
single cells- David Kent 
 
One long-standing challenge in stem cell biology is the identification of 
distinct molecular markers that would allow isolation of pure, functional HSCs. 
Over the last decades, a number of laboratories have developed different cell-
surface marker combinations or used reporter gene constructs to prospectively 
isolate HSCs with achieved purities ranging from 20 to 50% [11–15]. While some 
transplantation failures may be partially attributed to the technical challenges of 
single-cell transplants, it appears that a sizeable fraction of analyzed cells do not 
have stem-cell properties. These “contaminating cells” within the isolated HSC 
population therefore obscure subsequent functional or gene expression analyses. 
As mentioned above, a variety of functional assays have revealed vast 
heterogeneity within the HSC pool, since single stem cells show differences on 
lineage output [16–18], repopulation kinetics [19,20], and response to extrinsic 
factors [21]. 
To address these challenges, Dr Kent presented his recent work in the first 
part of the webinar. In collaboration with Bertie Gottgens’ laboratory, Dr. Kent 
hypothesized that comparing gene expression profiles of HSCs isolated with 
different strategies would reveal a conserved/overlapping molecular profile 
between HSCs that would not be shared by various contaminating cell fractions. 
Excluding contaminating cells based on the expected purity of each HSC 
population sorted, would thus reveal the molecular signature of “true” stem cells 
and lead to identification of markers enabling HSC isolation with higher purity. 
To test this hypothesis, they combined single-cell gene expression 
techniques with single-cell in vivo assays and bioinformatic analysis. Initially, they 
isolated HSCs through four different immunophenotypic strategies (CD34-Flt3-
CD48-CD150+KSL, CD45+EPCR+CD48-CD150+, CD34-Flt3-KSL and SP CD150+ 
KSL) as well as five types of progenitor cells. The expression of 43 genes was 
compared across those 9 cell populations (1800 single cells total) by single-cell 
qRT-PCR [22]. Using multidimensional mathematical analysis (t-distributed 
stochastic neighbor embedding analysis, t-SNE), they presented data in single-cell 
plots confirming that most cells of the same population clustered together. As 
initially hypothesized, they indeed identified a region where differently sorted HSC 
populations overlapped, thus sharing a common gene expression profile (termed 
molecular overlapping HSCs - MolO) compared to those outside that region (no 
molecular overlap - NoMo).  
Taking advantage of flow cytometric index-sorting, a technique which 
quantifies the intensity for all parameters used for the isolation of single cells, they 
were able to retrospectively link the cell-surface marker expression of sorted cells 
with their outcome in downstream assays [23,24]. This permitted Dr Kent and 
colleagues to associate gene expression data of MolO HSCs with the expression 
levels of all fluorescent markers used for their isolation. By doing so, they revealed 
that 28 of 43 genes were differentially expressed between HSCs located in the 
overlapping or non-overlapping region. Interestingly, MolO HSCs exhibited higher 
expression for Sca1 and CD150 and lower for CD48 than NoMo. To functionally 
test these results, CD48-CD150+Sca1+ HSCs were divided to Sca1 high (SLAM 
Sca1hi) or low expressing cells (SLAM Sca1lo) and their HSC potential was 
assessed in both in vitro and in vivo assays [22]. Monitoring the cell-cycle profile, 
colony size and immunophenotype after in vitro culture revealed that SLAM Sca1hi 
cells were enriched for behaviors typically associated with stem cells (slow division 
kinetics, small colony size, retaining cell surface marker expression in culture). 
SLAM Sca1hi HSCs led to higher donor chimerism while producing all 
hematopoietic lineages compared to the myeloid-deficient SLAM Sca1lo cells in 
bulk transplantation experiments. In addition, single-cell transplants illustrated that 
this 3-marker based strategy (CD48, CD150 and Sca1) yields HSCs with at least 
50% purity, comparable to previous schemes utilizing three markers (CD150, 
CD48, CD41) [12]. 
To further investigate the underlying HSC heterogeneity at the 
transcriptome level, single-cell RNA sequencing was performed and identified 
differential expression of 4533 genes between single CD34-Flt3-CD48-CD150+KSL 
cells. Going one step further, Dr Kent presented plots which could link these single-
cell RNA sequencing with single-cell transplantation data, since populations used 
in both assays were index-sorted for the exact same flow cytometry parameters. 
Bioinformatic analysis of those data identified EPCR as a marker positively 
correlating with retention of functional stem-cell properties, while negatively 
correlating with differentiation. Indeed, isolating SLAM Sca1hi EPCRhi cells 
improved HSC purity to almost 70% as shown by single-cell transplantations [22], 
providing a novel strategy for functional HSC isolation. 
 
Cellular Barcoding Following Multiple Single Cell Lineages in vivo - 
Leila Perié  
 
In her seminar Dr. Perié presented the methods utilized by her laboratory 
to perform barcoding and lineage tracing of hematopoietic progenitors. Her data 
demonstrate that lymphoid-primed multipotent progenitors and common myeloid 
progenitor populations are highly heterogeneous containing lineage restricted cells 
of different commitment potential.   
The Perié laboratory utilizes a library of small, non-coding, DNA sequences 
as barcodes. These are cloned into lentiviral vectors that also express a 
fluorescent reporter for easy isolation of transduced cells. For lineage tracing 
cultured hematopoietic progenitors are transduced with the lentiviral library. Those 
sequences will integrate into the genome of transduced cells allowing identification 
of their progeny by presence of unique DNA barcodes. The transduced progenitors 
are then injected into myeloablated recipients and the lineage contribution of each 
barcode is assessed by purifying specific hematopoietic populations at different 
time points after transplantation and performing nested PCR amplification and 
next-generation sequencing.  
During her seminar, Dr Perié emphasized on some important aspects of 
cellular barcoding. For this method to be successful, validating the ability of utilized 
viral vectors to transduce the cells of interest while keeping transduction efficiency 
low (between 5-10%) is essential to ensure a single DNA barcode per progenitor. 
The size of the library is also important: the number of cells to be transduced 
should be several orders of magnitude smaller than the diversity of the library (to 
ensure that each progenitor has a unique barcode). Also, the length of the 
barcodes will affect sequencing costs. Dr Perié recommended to sequence the full 
library before any experiment, in order to create a reference library and facilitate 
bioinformatics analysis of generated data. Another important consideration is 
controling the number of different progenitors transduced with the same barcode. 
To do so, Dr Perié suggested transplanting the pool of transduced cells into at 
least two separate recipients and check whether the same barcode appears in 
both mice. 
It is also important to be aware of the limitations of cellular barcoding. The 
first limitation is that it provides no information about the exact time of commitment; 
if a progenitor gives rise to two different cell types it is impossible to determine 
whether this occur early or late during cell maturation. It also provides no 
information whether the transduced progenitor underwent trans-differentiation or 
de-differentiation instead of commitment to one or more lineages. An important 
technical limitation is that the technique requires in vitro culture, use of lentivirus 
and lengthy transplantation of the transduced progenitors into myeloablated 
recipients. All those steps can affect lineage commitment decisions and not reflect 
actual lineage differentiation during homeostasis.  
Utilizing the methods described above, Dr. Perié presented data showing 
that early murine hematopoietic progenitors are highly heterogeneous and, in most 
cases, already committed to specific lineages. Transplanting lentivirally barcoded 
CD16/32-CD127-CD117hiSca1+CD135hi lymphoid-primed multipotent progenitors 
(LMPP) into myeloablated recipients revealed that LMPPs are extremely 
heterogeneous in their lineage output. Most LMPP were already committed to 
dendritic, myeloid or B-cell lineage and only a small fraction was capable of 
multilineage reconstitution [25]. There results demonstrated that LMPP could 
generate dendritic cells directly without passing through a common myeloid 
progenitor (CMP) or common lymphoid progenitor (CLP) stage [25]. These, 
together with mathematical modeling, suggested that the classical hematopoietic 
differentiation tree should be revised to include new LMPP sub-types [26]. Using 
the same technique, Dr. Perié examined lineage commitment to erythroid and 
myeloid lineages from the CMP stage. They found that the CMP population was 
also heterogeneous with most CMP already committed to either myeloid or 
erythroid lineages, whereas only 5% of CMP are bipotent [27]. These studies 
revealed the heterogeneity of hematopoietic progenitors defined by cell-surface 
markers and highlighted the power of cellular barcoding to investigate progenitors’ 
potential with single-cell resolution.  
 
Together, these single-cell methodologies and recent studies utilizing these 
powerful methods have provided insights into the heterogeneity of the primitive 
hematopoietic compartment including committed progenitor cells and not just the 
early stem cell compartment, rigorously defined a cell-surface marker combination 
for HSCs. Also, the power of single-cell studies was highlighted, which will soon 
become the norm for evaluating cell function and potential, as further optimization 
and enhancements of current methods to analyze genome-wide information 
generated from single cells is ongoing.  
 
 The webinar can be viewed at the ISEH website at: http://iseh.site-
ym.com/?ISEHWebinars 
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 Figure legend 
 
Figure 1: Single-cell methods to define properties of individual cells that are 
masked in population-based experimental paradigms. Index sorting allows for 
the retrospective analysis of FACs data post experiment (ie after RNA-
Sequensing, single-cell transplant, clonal culture assays). Lentiviral barcoding 
allows for tagging a plethora of single cells (after purification or enrichment of a 
population) that can then be used to track individual cells’ potential. There are 
benefits and drawbacks to each method, but both have been utilized to establish 
more in-depth appreciation of the heterogeneity in primitive hematopoietic cell 
potential.  
  
 
